Companies: 10,795·Total market cap: $144.5T
Abcam plc

Abcam plc

ABCMNASDAQHealthcare
$23.99
+$0.01(+0.04%)
Market Cap$5.5B
P/E Ratio
52W High$25.32
52W Low$12.48

Abcam plc (ABCM) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · ABCM · as of Dec 31, 2023

Ownership Breakdown

Institutions 0%
Insiders 16.39%
Public 83.61%

2

Institutional Holders

▼ 241 vs Q3

$29,821

Total Inst. Value

▼ $4.45B vs Q3

230.15M

Shares Outstanding

freeFloat 83.61%

1,755

13F Shares Held

▼ 196.80M vs Q3

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

ABCM largest shareholders · institutional ownership

Q4 2023 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

STATE OF WYOMING

biological products, (no diagnostic substances)

1.4K0.06%

0.06%

$20.82MFeb 15, 2024 7.0K

RONALD BLUE TRUST, INC.

biological products, (no diagnostic substances)

3850.02%

0.02%

$9.00MJan 18, 2024NEW

US BANCORP \DE\

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 9, 2024EXIT

BANK OF AMERICA CORP /DE/

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 14, 2024EXIT

WELLS FARGO & COMPANY/MN

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 9, 2024EXIT

PRICE T ROWE ASSOCIATES INC /MD/

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 16, 2024EXIT

BARCLAYS PLC

biological products, (no diagnostic substances)

00.00%

0.00%

$0Mar 24, 2026EXIT

STATE STREET CORP

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 14, 2024EXIT

FMR LLC

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 13, 2024EXIT

M&T BANK CORP

biological products, (no diagnostic substances)

00.00%

0.00%

$0Feb 6, 2024EXIT

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q4 2023 vs prior quarter

Q4 2023

Net institutional sentimentBearish — more selling than buying

0

Increased

+0 shares

1

New Positions

first time holders

1

Decreased

−7.0K shares

48

Sold Out

fully exited

Net shares change (top 50)

7.0K

+0 / −7.0K

Net new holders

-48

1 new / 48 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

ABCM insider trading · insider activity

Source: SEC Form 4

Recent Insider Transactions

Showing 10 most recent · Common Stock only

No recent insider transactions reported.

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Abcam plc (ABCM) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 16.39%, while retail and public investors account for the remaining 83.61%.

The largest institutional shareholder of Abcam plc is STATE OF WYOMING, holding approximately 1,370 shares — equal to 0.06% of outstanding shares — as of December 31, 2023.

A total of 2 institutional investors currently hold ABCM stock, with a combined institutional value of approximately $29,821 as of the most recent 13F filing period.

Frequently asked questions

ABCM ownership

Abcam plc (ABCM) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is STATE OF WYOMING with a 0.06% stake. Company insiders hold 16.39%. Data sourced from SEC Form 13F as of December 31, 2023.

who owns ABCM stockABCM ownership structureSEC Form 13F institutional holdingsABCM float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of December 31, 2023